CSP exam with 100% All correct answers Updated 2024
Which medication would be an appropriate choice for a patient who has an eGFR <30ml/min? a. Epclusa (velpatasvir/sofosbuvir) b. Vosevi (velpatasvir/sofosbuvir/voxilaprevir) c. Harvoni (ledipasvir/sofosbuvir) d. Mavyret (glecaprevir/pibrentasvir) - ANSWER-d. Mavyret (glecaprevir/pibrentasvir) A 30 year old female MS patient states she's thinking about starting a family. What would you tell her about the treatment options for MS and pregnancy? a. Aubagio (teriflunomide) has no pregnancy precautions and would be a good option for her. b. Aubagio (teriflunomide) has been shown to cause birth defects and can take up to 2 months to be eliminated from the body. c. Copaxone (glatiramer) is rated category B in pregnancy and a possible option for treatment during pregnancy. d. Betaseron (interferon - ANSWER-c. Copaxone (glatiramer) is rated category B in pregnancy and a possible option for treatment during pregnancy. A 45 y/o, 200lb patient is struggling with severe dermatitis and the provider wants to potentially start a biologic. Which medication would you recommend? a. Protopic (tacrolimus) b. Humira (adalimumab) c. Stelara (ustekinumab) d. Dupixent (dupilumab) - ANSWER-d. Dupixent (dupilumab) A 45-year-old male with pancreatic cancer is given a prescription for Tarceva (erlotinib). He states that he currently smokes about one pack of cigarettes a day. How should you consult the patient? a. Smoking increases Tarceva levels and he will experience more side effects if he continues to smoke b. Smoking decreases Tarceva levels and the medication will be less effective if he continues to smoke c. Tarceva levels aren't affected by tobacco use d. Smoking while taking Tarceva is contraindicated - ANSWER-b. Smoking decreases Tarceva levels and the medication will be less effective if he continues to smoke A 56 y/o M is diagnosed with metastatic, castration-resistant prostate cancer and the provider asks which oral antiandrogen you recommend. He has a past medical history including hypertension and poorly controlled type II diabetes. What is your recommendation? a. Zytiga (abiraterone acetate) 1000mg once daily with prednisone b. Xtandi (enzalutamide) 160mg once daily with prednisone c. Xtandi (enzalutamide) 160mg once daily d. Zytiga (abiraterone acetate) 1000mg once daily - ANSWER-c. Xtandi (enzalutamide) 160mg once daily A 56 y/o, 140lb patient with psoriasis will be starting Stelara (ustekinumab), but the provider wants to verify the dosing of the medication. What starting dose would you recommend? a. Inject 45 mg subcutaneously at weeks 0 and 4, followed by 45 mg every 12 weeks b. Inject 90 mg subcutaneously at weeks 0 and 4, followed by 90 mg every 12 weeks c. Infuse 260 mg IV over at least 1 hour as a single dose, followed 8 weeks later with 90 mg subcutaneously every 8 weeks d. Infuse 520 mg IV over at least 1 hour as a single dose, followed 8 weeks later with 90 mg subcutaneously every 8 weeks - ANSWER-a. Inject 45 mg subcutaneously at weeks 0 and 4, followed by 45 mg every 12 weeks
Written for
- Institution
- CSP - Certified Scrum Professional
- Course
- CSP - Certified Scrum Professional
Document information
- Uploaded on
- July 13, 2024
- Number of pages
- 13
- Written in
- 2023/2024
- Type
- Exam (elaborations)
- Contains
- Questions & answers
Subjects
-
csp exam with 100 all correct answers updated